Ushiku, Japan

Mitsuhiro Ino


 


Average Co-Inventor Count = 10.0

ph-index = 5

Forward Citations = 57(Granted Patents)


Location History:

  • Ibaraki, JP (2006)
  • Ushiku, JP (2006 - 2010)

Company Filing History:


Years Active: 2006-2010

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Mitsuhiro Ino: Innovator in Pharmaceutical Chemistry

Introduction

Mitsuhiro Ino is a prominent inventor based in Ushiku, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 9 patents. His work focuses on developing novel compounds with therapeutic applications.

Latest Patents

One of Mitsuhiro Ino's latest patents is for an Imidazo[1,2-b]pyridazine compound. This invention provides a novel compound that exhibits excellent corticotrophin-releasing-factor receptor antagonistic activity. The compound is represented by a specific formula, which includes various substituents such as hydrogen atoms, Calkyl groups, and halogen atoms. Another notable patent involves Pyrazolo[1,5-a]pyridines and medicines containing these compounds, which are represented by a general formula with multiple substituents.

Career Highlights

Throughout his career, Mitsuhiro Ino has worked with notable companies in the pharmaceutical industry, including Eisai Company, Limited and Eisai R&D Management Co., Ltd. His innovative work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Mitsuhiro Ino has collaborated with esteemed colleagues such as Shigeki Hibi and Yorihisa Hoshino. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Mitsuhiro Ino's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field and advance therapeutic options for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…